Overview

The purpose of the Harm Reduction Summit is to provide the opportunity for individuals to learn more about evidence-based best practices regarding harm reduction/disease prevention strategies and broaden the impact of implementing evidence-based best practices in the realm of harm reduction operations throughout Kentucky. The Summit is open to Harm Reduction Care Navigators, intra/inter-state Public Health Professionals, First Responders, Local and State Government Officials, Educators, Community Leaders, Public Health Professionals, and other professionals who work in Harm Reduction. The summit will highlight best practices, statues, and policies related to implement and maintaining harm reduction programs throughout the Commonwealth of Kentucky. The Summit will focus on Harm Reduction, disease prevention, including Hepatitis C (HCV), and Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS), opioid use disorder (OUD), stimulant use disorder (StUD), substance use disorder (SUD), mental health, and other Harm Reduction-related topics.

Accreditation

In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral Kentucky Cabinet for Health and Family Services, and Kentucky Department for Public Health. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

This live activity is designated for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This training has been approved by the KBML as meeting the statutory requirements of HB1. ID# 0525-H7.0-UK5A.

CPE

This knowledge-based activity will award 7.25 contact hours (0.725 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

ASWB ACE

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 7.25 continuing education credits.

CNE

The maximum number of hours awarded for this Continuing Nursing Education activity is 7.25 nursing contact hours.

EMS

The Kentucky Board of Emergency Medical Services (KBEMS) certifies that this educational activity is designated for 7.25 KBEMS contact hours.

CHES

Sponsored by Department of Public Health, Western Kentucky University, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 7.25 total Category I continuing education contact hours. Maximum advanced-level continuing education contact hours available are 0.   Provider ID# 105862      Event ID# ­­­­61064-61077

CADC 

This activity has been approved for 7.25 hours to meet the continuing education requirements for credential renewal.

CCHW

This training is approved by the Office of Community Health Workers Program to provide 7.25 continuing education units for Certified Community Health Workers.

Other

UK Healthcare CECentral certifies this activity for 7.25 hours of participation.

Acknowledgement

The 2025 Kentucky Harm Reduction Summit is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of cooperative agreement 1 NU17CE010186 totaling $10,814,838 with 0% financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC, HHS, or the U.S. government. For more information, please visit CDC.gov.